Leukemia & Lymphoma Society (LLS): Chronic Myeloid Leukemia (CML)

Not Funded
About
The Leukemia & Lymphoma Society (LLS) offers a comprehensive program for patients diagnosed with Chronic Myeloid Leukemia (CML), providing support for medications such as Bosulif, Gleevec, Iclusig, Mekinist, Sprycel, Tasigna, and others. The LLS program ensures that eligible U.S. residents with appropriate insurance coverage and confirmed blood cancer diagnoses can access necessary chemotherapy treatments. By using the Leukemia & Lymphoma Society's CML program, patients can efficiently manage their treatment needs and medication costs.
Insurance requirements: Commercially insured, Medicare / Medicaid, Underinsured
Enrollment Forms
Enrollment Form
Benefits
$2000 annual maximum benefit
Program Requirements
Valid only for residents in the US and Puerto Rico
Enrollment Required: Yes
Coverage Required: No
Needs Based: Yes
Activation Required: No
Program Details
Please note that specific drug coverage is not indicated on program website; drug coverage must be verified by calling program at 8775572672
LLS covers all products prescribed by the patient’s physician to treat their primary cancer diagnosis classified as a chemotherapy or prescription related to their covered diagnosis
All products must be covered by the patient’s primary insurance provider
Patients, caregivers, pharmacies, and healthcare providers can apply by phone or online
Patients must have a valid email address to register & providers will need their NPI
Once registered, patients will receive an email directing to a website to create a password; application form can then be entered
To apply, patient will need to supply SSN or Alien ID, DOB, diagnosis, insurance details (group, policy, and ID numbers), Medicare/Medicaid info, physician, and pharmacy details
Once the application is submitted, the approval/denial or pending status will be provided immediately
If the application is approved, the patient can begin using the award right away with the virtual pharmacy copay card that will be attached to the award message
LLS will fax a physician's form to the treating HCP; the completed form must be received within 30 days of the approval, or the award will be closed, and no further claims may be submitted
Any required documentation can be uploaded to the portal, as well as claim submissions and payment requests
Other Programs

Accessia Health: Chronic Myeloid Leukemia (C.M.L.) - Private Insurance: Waitlist

Commercially Insured
Underinsured
Uninsured
Max Saving: $5000/year*

Accessia Health: Chronic Myeloid Leukemia (C.M.L.) - Public Insurance: Waitlist

Medicare / Medicaid
Max Saving: $5000/year*
Other Tools for Sprycel